?(CA)Routes ?Letrozole (INN, trade name Femara®) is an oral non-steroidal aromatase inhibitor that has been used for ovulation induction by fertility doctors since 2001; having less side-effects than clomiphene citrate (Clomid®) for the adjuvant treatment femara cancer drug hormonally-responsive femara cancer drug cancerEstrogens are.

is used to femara cancer drug endometriosis.[2][edit] References^ Tulandi femara cancer drug femara cancer drug J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006 femara cancer drug 28. PMID 16650422^ Endometriosis ESHRE abstract LetrozoleFrom Wikipedia, the free encyclopedia(Redirected from Femara)Jump to: navigation, searchLetrozoleSystematic (IUPAC) name4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrileIdentifiersCAS number 112809-51-5ATC code L02BG04PubChem 3902DrugBank APRD01066Chemical dataFormula C17H11N5Mol. mass 285.303 g/molSMILES femara cancer drug femara cancer drug PubChemPharmacokinetic dataBioavailability 99.9%Protein binding 60%, mainly to albuminMetabolism ?Half life 2 daysExcretion ?Therapeutic considerationsPregnancy cat. ?Legal status ?(CA)Routes ?Letrozole (INN, trade name Femara®) is an oral non-steroidal aromatase inhibitor that has been used to treat endometriosis.[2][edit] References^.

of Reproductive Medicine 2005 Conference suggests that it may increase the risk of birth defects.